A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Fasting Conditions

NCT00865696 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Mirtazapine 15 mg tablets, single dose
DRUG: REMERON® 15 mg tablets, single dose

Sponsor

Actavis Inc.